|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19,519.45 INR | +3.53% |
|
+3.93% | +28.50% |
| Market Cap | 250B 2.62B 2.3B 2.12B 1.96B 3.72B 3.78B 25.35B 9.94B 123B 9.85B 9.64B 426B | P/E 2026 |
42.3x | P/E 2027 * | 59.7x |
|---|---|---|---|---|---|
| Enterprise Value | 250B 2.62B 2.29B 2.12B 1.96B 3.72B 3.78B 25.34B 9.93B 123B 9.84B 9.63B 426B | EV / Sales 2026 |
7.59x | EV / Sales 2027 * | 11x |
| Free-Float |
62.24% | Yield 2026 |
0.28% | Yield 2027 * | 0.07% |
Last Transcript: Neuland Laboratories Limited
| 1 day | +3.53% | ||
| 1 week | +3.93% | ||
| Current month | +4.77% | ||
| 1 month | +15.09% | ||
| 3 months | +38.92% | ||
| 6 months | +31.76% | ||
| Current year | +28.50% |
| 1 week | 18,400 | 20,072 | |
| 1 month | 16,569.95 | 20,072 | |
| Current year | 11,500 | 20,072 | |
| 1 year | 11,500 | 20,072 | |
| 3 years | 2,871.4 | 20,072 | |
| 5 years | 965.85 | 20,072 | |
| 10 years | 247.3 | 20,072 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 01/04/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 23/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/08/2025 | |
| Director/Board Member | 80 | 31/10/2022 | |
| Director/Board Member | 82 | 12/02/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.53% | +3.93% | +67.20% | +530.24% | 2.53B | ||
| -0.32% | -0.06% | +54.17% | +167.72% | 1,084B | ||
| -1.27% | -1.65% | +65.53% | +62.18% | 634B | ||
| -2.08% | -4.61% | +30.64% | +85.17% | 447B | ||
| +0.18% | -1.76% | +29.04% | +26.48% | 330B | ||
| -6.22% | -8.14% | +28.87% | +31.18% | 295B | ||
| -1.27% | -2.91% | +27.42% | +44.91% | 285B | ||
| -0.93% | -3.57% | -27.74% | -39.70% | 218B | ||
| -1.32% | -2.83% | +22.60% | +61.77% | 199B | ||
| +0.75% | +2.65% | +19.00% | +78.03% | 169B | ||
| Average | -0.90% | +2.31% | +31.67% | +104.80% | 366.24B | |
| Weighted average by Cap. | -1.25% | +2.48% | +38.69% | +84.13% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 17.64B 185M 162M 149M 138M 262M 266M 1.79B 700M 8.66B 694M 679M 30B | 23.09B 242M 212M 195M 181M 343M 348M 2.34B 916M 11.34B 908M 888M 39.27B |
| Net income | 2.57B 26.95M 23.58M 21.74M 20.12M 38.18M 38.82M 260M 102M 1.26B 101M 98.99M 4.38B | 4.21B 44.1M 38.58M 35.58M 32.92M 62.48M 63.52M 426M 167M 2.07B 166M 162M 7.16B |
| Net Debt | -117M -1.22M -1.07M -985K -911K -1.73M -1.76M -11.79M -4.62M -57.21M -4.58M -4.48M -198M | 2.94B 30.77M 26.92M 24.83M 22.97M 43.6M 44.33M 297M 117M 1.44B 116M 113M 5B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/07/26 | ₹19,519.45 | +3.53% | 3,876 |
| 08/07/26 | ₹18,854.00 | -0.29% | 2,572 |
| 07/07/26 | ₹18,908.70 | +0.26% | 1,093 |
| 06/07/26 | ₹18,858.95 | -0.30% | 976 |
| 03/07/26 | ₹18,916.45 | -0.35% | 21,846 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















